Cutaneous Leishmaniasis Terminated Phase 3 Trials for Meglumine antimoniate (DB13732)

Also known as: Leishmaniasis, Cutaneous / Cutaneous leishmaniasis (disorder)

IndicationStatusPhase
DBCOND0028439 (Cutaneous Leishmaniasis)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01953744High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and ManausTreatment
NCT00317629Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous LeishmaniasisTreatment